Lynne Kaminer

Multicenter Phase 2 Trial of Rituximab for Waldenström Macroglobulinemia (WM): An Eastern Cooperative Oncology Group Study (E3A98)

Morie A. Gertz, Montserrat Rué, Emily Blood et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2004 · 197 citations

Medicine, Oncology, Pharmacotherapy +10

Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial

Drew J. Winston, Kathleen M. Mullane, Oliver A. Cornely et al. · The Lancet · 2018 · 96 citations

Veterinary Medicine, Immunology, Infectious Diseases +16

Does younger donor age affect the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies beneficially?

Jayesh Mehta, Leo I. Gordon, Martin S. Tallman et al. · Bone Marrow Transplantation · 2006 · 65 citations

Medicine, Hematology, Immunology +12

Economic analysis of a randomized placebo-controlled phase III study of granulocyte macrophage colony stimulating factor in adult patients ( > 55 to 70 years of age) with acute myelogenous leukemia

Charles L. Bennett, T J Stinson, Martin S. Tallman et al. · Annals of Oncology · 1999 · 58 citations · Full text

Medicine, Hematology, Immunology +11

A phase I-II study of bialkylator chemotherapy, high-dose thiotepa, and cyclophosphamide with autologous bone marrow reinfusion in patients with advanced cancer.

Stephanie Williams, Jacob D. Bitran, Lynne Kaminer et al. · Journal of Clinical Oncology · 1987 · 57 citations

Medicine, Hematology, Pharmacology +17